Antiretroviral Therapy Outcomes in HIV-Infected Children after Adjusting Protease Inhibitor Dosing during Tuberculosis Treatment

• Cordula Frohoff,

  Affiliation Gertrude H. Sergievsky Center, College of Physicians and Surgeons, and Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, United States of America

  ⨯
• Magendhree Moodley,

  Affiliation Wits Institute for Sexual Reproductive Health HIV & Related Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Lee Fairlie,

  Affiliation Wits Institute for Sexual Reproductive Health HIV & Related Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Ashraf Coovadia,

  Affiliation Empilweni Services and Research Unit, Rahima Moosa Mother and Child Hospital, Department of Paediatrics, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Harry Moultrie,

  Affiliation Wits Institute for Sexual Reproductive Health HIV & Related Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Louise Kuhn,

  Affiliation Gertrude H. Sergievsky Center, College of Physicians and Surgeons, and Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, United States of America

  ⨯
• Tammy Meyers

  * E-mail: tammy@meyers.net

  Affiliation Harriet Shezi Clinic, Chris Hani Baragwanath Hospital, Department of Paediatrics, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

  ⨯